AC Immune

AC Immune

AC Immune SA operates as a biopharmaceutical company. This Company discovers, designs, and develops medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. As a result, ACImmune enable the prevention of Alzheimer’s disease earlier so the treatment is more efficient.

 

 

 

 

Fact

Second IPO of a Swiss biotech company in 2016

 

 

215

employees

334 mio $

market cap

Other Success Stories